⌘K

Login Start Free

Home/Filings/4/0001209191-10-008669

4//SEC Filing

Mayers Douglas L 4

Accession 0001209191-10-008669

CIK 0001093649other

View on SEC.gov Company Profile

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 6:07 PM ET

Size

5.8 KB

Accession

0001209191-10-008669

Insider Transaction Report

Form 4

Period: 2010-02-10

IDENIX PHARMACEUTICALS INCIDIX

Mayers Douglas L

EVP and Chief Medical Officer

Transactions

Award
Employee Stock Option (Right to Buy)
2010-02-10+40,000→ 40,000 total
Exercise: $2.96Exp: 2020-02-09→ Common Stock (40,000 underlying)

Footnotes (1)

[F1]The option vests in 48 equal monthly installments beginning on February 28, 2010.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

IDENIX PHARMACEUTICALS INC

CIK 0001093649

Entity typeother

Related Parties

1

filerCIK 0001393646

Filing Metadata

Form type: 4
Filed: Feb 10, 7:00 PM ET
Accepted: Feb 11, 6:07 PM ET
Size: 5.8 KB

View on SEC.gov